Understanding how PARP-1 helps repair DNA damage

Tuning PARP-1 retention and release on DNA breaks

NIH-funded research University of Pennsylvania · NIH-11042271

This study is looking at how a protein called PARP-1 helps fix DNA damage, which could lead to better treatments for cancer and other related conditions, so patients can learn how to improve their care.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11042271 on NIH RePORTER

What this research studies

This research investigates the role of PARP-1, a protein that responds to DNA breaks, in the repair of genetic damage. By examining how PARP-1 binds to and modifies proteins at sites of DNA damage, the study aims to uncover the mechanisms that regulate its activity. This could lead to improved therapies for cancer and other conditions related to DNA damage. Patients may benefit from insights into how to enhance or inhibit PARP-1 activity for better treatment outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with cancers that are known to involve DNA repair deficiencies.

Not a fit: Patients with conditions unrelated to DNA damage or those not affected by cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer therapies that target DNA repair mechanisms.

How similar studies have performed: Previous research has shown promising results with PARP inhibitors in cancer treatment, indicating that this approach has potential for success.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.